Published in

American Association for the Advancement of Science, Science, 6570(374), p. 995-999, 2021

DOI: 10.1126/science.abj9932

Links

Tools

Export citation

Search in Google Scholar

Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India

Journal article published in 2021 by Mahesh S. Dhar, Robin Marwal, Radhakrishnan Vs, V. S. Radhakrishnan, Kalaiarasan Ponnusamy, Bani Jolly, Rahul C. Bhoyar, Viren Sardana, Salwa Naushin, Mercy Rophina, Thomas A. Mellan, Swapnil Mishra ORCID, Charles Whittaker, Saman Fatihi, Meena Datta and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Deadly surge in Delhi In the spring of 2021, Delhi, India experienced a wave of coronavirus cases that overwhelmed healthcare services despite the population showing a high level of immune positivity. Dhar et al . collated a mixture of serosurveillance, quantitative polymerase chain reaction, and genomic data, finding that waves of variants had passed through the Delhi population during 2020 and 2021. The alpha (B.1.1.7) variant dominated in March 2021 and was rapidly replaced by the delta (B.1.617.2) variant in April and May 2021. The delta variant outcompeted its predecessors by mutations that enhanced replication, immune evasion, and host receptor avidity, thus increasing transmissibility, reinfection, and vaccination breakthrough. —CA